CLIMB BIO INC. - COMMON STOCK
3.0500
22-نوفمبر-24 16:44:58
15 متأخرة بدقائق
الأسهم
+0.0500
+1.67%
نطاق اليوم
3.0150 - 3.3000
ISIN
N/A
المصدر
NASDAQ
-
Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights
12 نوفمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire
-
Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board
11 نوفمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire
-
Climb Bio to Present at Upcoming Investor Conferences
31 أكتوبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire
-
Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event
15 أكتوبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire
-
11 أكتوبر 2024 12:30:00 بحسب Nasdaq GlobeNewswire
-
04 أكتوبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire
-
Climb Bio to Host Virtual Investor Event on October 15, 2024
03 أكتوبر 2024 10:00:16 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.
02 أكتوبر 2024 09:00:23 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
11 سبتمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics Announces Additions to its Leadership Team
26 أغسطس 2024 07:00:00 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports Second Quarter Financial Results
14 أغسطس 2024 06:05:00 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
28 يونيو 2024 07:00:00 بحسب Nasdaq GlobeNewswire
-
27 يونيو 2024 16:01:00 بحسب Nasdaq GlobeNewswire
-
11 أبريل 2024 07:00:00 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics Announces Plans to Explore Strategic Alternatives
20 يوليو 2023 06:45:00 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights
11 مايو 2023 16:10:00 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights
06 مارس 2023 16:10:00 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics Provides Strategic Update and Announces Leadership Transition
09 فبراير 2023 16:01:00 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conference
30 نوفمبر 2022 07:00:00 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports Third Quarter Financial and Business Highlights
14 نوفمبر 2022 06:10:00 بحسب Nasdaq GlobeNewswire
- <<
- <
- 1
- >